State attorneys general
Executive Summary
Multi-state action against manufacturer for drug program is imminent, according to one state AG office. Action, apparently similar to Miles" consent decree with 11 AGs regarding its Adalat CC program ("The Pink Sheet" April 11, p. 3), may be announced early in week of Aug. 1